NCT03389100

Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.

Enrolling by Invitation
PHASE2Ages 55–69InterventionalDiagnostic
Columbia University
~600 participants
Updated 2025-05-06 on ClinicalTrials.gov
What's tested:18F-MK6240 injection

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
18F-MK6240 standardized update value ratio (SUVR)
Measured over 18 to 30 months
Diabetes Mellitus, Type 2
Pre-diabetes

NCT03389100

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Columbia University Irving Medical Center

    New York, New Yorkno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Jose A. Luchsinger, MD · PRINCIPAL_INVESTIGATOR · Columbia University

This trial hasn't published a contact. View it on ClinicalTrials.gov

  • 18F-MK6240 standardized update value ratio (SUVR)18 to 30 months

    The primary outcome measure will be regional standardized uptake value ratio (SUVR) values for 18F-MK-6240 using cerebellum as reference region. Kinetic modeling using Logan DVR method may also be employed. Multiple brain regions will be measured, with particular attention to medial temporal cortex structures such as hippocampus and entorhinal cortex